doi: 10.1158/2159-8290.CD-ND2013-025.
Epub 2013 Nov 7.
Targeting resistance in lung cancer
- PMID: 24327718
- DOI: 10.1158/2159-8290.CD-ND2013-025
Item in Clipboard
Targeting resistance in lung cancer
Cancer Discov.
2013 Dec.
No abstract available
Similar articles
-
Targeted therapy in lung cancer: survival, quality of life improved for some patients.Cancer. 2014 Sep 1;120(17):2625-6. doi: 10.1002/cncr.28943. Cancer. 2014. PMID: 25142921 No abstract available.
-
Does the addition of vascular endothelial growth factor inhibitors to epidermal growth factor receptor-tyrosine kinase inhibitor overcome T790M acquired resistance?J Thorac Oncol. 2011 Feb;6(2):404. doi: 10.1097/JTO.0b013e318204a1dc. J Thorac Oncol. 2011. PMID: 21252723 No abstract available.
-
The impact of epidermal-growth-factor-receptor mutations in response to lung-cancer therapy.Nat Clin Pract Oncol. 2004 Nov;1(1):2-3. doi: 10.1038/ncponc0007. Nat Clin Pract Oncol. 2004. PMID: 16264773 Review. No abstract available.
-
Genetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer--a review of the literature.Oncologist. 2007 Feb;12(2):201-10. doi: 10.1634/theoncologist.12-2-201. Oncologist. 2007. PMID: 17296816 Review.
-
Strategies for overcoming acquired resistance to epidermal growth factor receptor: targeted therapies in lung cancer.Arch Pathol Lab Med. 2012 Oct;136(10):1205-9. doi: 10.5858/arpa.2012-0254-RA. Arch Pathol Lab Med. 2012. PMID: 23020725 Review.
Cited by
-
Noninvasive saliva-based EGFR gene mutation detection in patients with lung cancer.Am J Respir Crit Care Med. 2014 Nov 15;190(10):1117-26. doi: 10.1164/rccm.201406-1003OC. Am J Respir Crit Care Med. 2014. PMID: 25317990 Free PMC article. Clinical Trial.
-
Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data.Braz J Med Biol Res. 2014 Nov;47(11):929-39. doi: 10.1590/1414-431X20144099. Epub 2014 Sep 5. Braz J Med Biol Res. 2014. PMID: 25296354 Free PMC article. Review.
-
Systemic treatment in EGFR-ALK NSCLC patients: second line therapy and beyond.Cancer Biol Med. 2014 Sep;11(3):173-81. doi: 10.7497/j.issn.2095-3941.2014.03.003. Cancer Biol Med. 2014. PMID: 25364578 Free PMC article. Review.
-
Quantification and dynamic monitoring of EGFR T790M in plasma cell-free DNA by digital PCR for prognosis of EGFR-TKI treatment in advanced NSCLC.PLoS One. 2014 Nov 18;9(11):e110780. doi: 10.1371/journal.pone.0110780. eCollection 2014. PLoS One. 2014. PMID: 25405807 Free PMC article.
-
Experience with afatinib in patients with non-small cell lung cancer progressing after clinical benefit from gefitinib and erlotinib.Oncologist. 2014 Oct;19(10):1100-9. doi: 10.1634/theoncologist.2014-0103. Epub 2014 Sep 17. Oncologist. 2014. PMID: 25232040 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
